Japan's Takeda Pharmaceutical Co. Ltd. ( TAK ,4502.T) announced Monday positive new data from VERDICT (NCT04259138), a Phase 4 ENTYVIO clinical trial, in ulcerative colitis or UC-related complication.
HALIFAX, Nova Scotia — Today Emera (TSX/NYSE: EMA) announced that it will release its Q3 2026 results and outline its 5-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results